Literature DB >> 8384777

Comparison of the effects of intra-third ventricular administration of interleukin-1 or platelet activating factor on ACTH secretion and the sympathetic-adrenomedullary system in conscious rats.

K Hashimoto1, R Hirasawa, S Makino.   

Abstract

The effects of centrally administered interleukin-1 beta (IL-1) or platelet activating factor (PAF) on adrenocorticotropin (ACTH) and catecholamine secretion, blood pressure and heart rate were examined to determine if these agents stimulate similarly the hypothalamic-pituitary-adrenal (HPA) axis or the sympathetic-adrenomedullary system. Intra-third ventricular administration of IL-1 (50, 200 ng) evoked significant ACTH secretion. Centrally administered IL-1 (50 ng) elevated plasma noradrenaline and adrenaline levels, systolic blood pressure and heart rate. Plasma ACTH, noradrenaline and adrenaline levels were also increased by the higher dose (200 ng) of IL-1 while systolic blood pressure and heart rate were not affected. Intra-third ventricular administration of 9 micrograms of PAF elevated the plasma ACTH level while 3 micrograms of PAF did not stimulate ACTH secretion. Neither dose of centrally administered PAF affected any plasma catecholamine level or systolic blood pressure. These results suggest that central IL-1 stimulates both the HPA axis and the sympathetic-adrenomedullary system, that a higher dose of IL-1 stimulates a mechanism to antagonize the elevation of blood pressure and heart rate and that central PAF is not involved in the control of the sympathetic-adrenomedullary system. Thus, IL-1 and PAF do not interact in the brain, although they interact peripherally.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384777     DOI: 10.18926/AMO/31608

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  5 in total

1.  Possible involvement of glucocorticoids in the modulation of interleukin-1-induced cardiovascular responses in rats.

Authors:  T Watanabe; N Tan; Y Saiki; T Makisumi; S Nakamura
Journal:  J Physiol       Date:  1996-02-15       Impact factor: 5.182

2.  Interleukin-1 may link helplessness-hopelessness with cancer progression: a proposed model.

Authors:  Miriam Argaman; Yori Gidron; Shmuel Ariad
Journal:  Int J Behav Med       Date:  2005

3.  Glucocorticoids reduce interleukin-1 concentration and result in neuroprotective effects in rat heatstroke.

Authors:  C C Liu; C H Chien; M T Lin
Journal:  J Physiol       Date:  2000-09-01       Impact factor: 5.182

4.  Expression of interleukin-1 in human pheochromocytoma.

Authors:  S R Bornstein; M Ehrhart-Bornstein; J González-Hernández; S Schröder; W A Scherbaum
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

Review 5.  Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis.

Authors:  Collin J Byrne; Sandhya Khurana; Aseem Kumar; T C Tai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-28       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.